Home › Funds › PFM Health Sciences, LP › TAK

PFM Health Sciences, LP position in TAK

TAKEDA PHARMACEUTICAL CO LTD · Health Care

PFM Health Sciences, LP reported holding 567,101 shares of TAK (TAKEDA PHARMACEUTICAL CO LTD) in its Q3 2026 13F filing — a position valued at US$10.3M, representing 1.05% of its reported portfolio and ranking #37 among its reported holdings. PFM Health Sciences, LP has disclosed TAK holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)567.10K sh
Reported value held$10.32M
Portfolio Weight1.05%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's TAK position evolved

PFM Health Sciences, LP first disclosed a stake in TAK in Q2 2026 at 444,173 shares (US$7.1M). The position peaked in Q3 2026 at 567,101 shares, worth US$10.3M. Across 2 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 567,101 shares valued at US$10.3M — an increase of 122,928 shares quarter over quarter.. Notable position changes include a 28% increase in Q3 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 444.17K $7.12M New
Q3 2026 567.10K $10.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TAK and 13F data

TAK (TAKEDA PHARMACEUTICAL CO LTD) is a Health Care company. 32 other funds we track also report a position in TAK — the largest reported positions include MANAGED ASSET PORTFOLIOS, LLC (US$33.0M), XY Capital Ltd (US$25.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TAK

All TAK fund holders →

FAQ

How long has PFM Health Sciences, LP held TAK?

PFM Health Sciences, LP has disclosed TAK holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is PFM Health Sciences, LP's current position in TAK?

As of Q3 2026, PFM Health Sciences, LP holds 567.10K shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), valued at $10.32M, representing 1.05% of its reported portfolio and ranking #37.

Has PFM Health Sciences, LP been buying or selling TAK?

In the latest 13F filing (Q3 2026), PFM Health Sciences, LP increased its position in TAK. The position peaked in Q3 2026 at 567.10K shares.

Which other funds hold TAK?

Other major institutional holders of TAK include MANAGED ASSET PORTFOLIOS, LLC, XY Capital Ltd, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.